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Optimization of oligonucleotide arrays and RNA amplification protocols for analysis of transcript structure and alternative splicing Microarrays offer a high-resolution means for monitoring pre-mRNA splicing on a genomic scale. We have developed a novel, unbiased  amplification protocol that permits labeling of entire transcripts. Also, hybridization conditions, probe characteristics, and analysis algo- rithms were optimized for detection of exons, exon-intron edges, and exon junctions. These optimized protocols can be used to detect small  variations and isoform mixtures, map the tissue specificity of known human alternative isoforms, and provide a robust, scalable platform  for high-throughput discovery of alternative splicing.
Abstract
Microarrays offer a high-resolution means for monitoring pre-mRNA splicing on a genomic scale.
We have developed a novel, unbiased amplification protocol that permits labeling of entire
transcripts. Also, hybridization conditions, probe characteristics, and analysis algorithms were
optimized for detection of exons, exon-intron edges, and exon junctions. These optimized
protocols can be used to detect small variations and isoform mixtures, map the tissue specificity of
known human alternative isoforms, and provide a robust, scalable platform for high-throughput
discovery of alternative splicing.
Background
As the sequencing of the human and mouse genomes nears
completion, the apparently similar number of genes in spe-
cies of different complexities suggests that other sources of
genomic richness are important, s u c h  a s  g e n e  r e g u l a t i o n ,
post-translational modification, and alternative splicing [1].
Recent estimates from expressed sequence tag (EST) studies
indicate that 40-60% of human genes are alternatively
spliced [2,3], and in many cases alternative isoforms result in
proteins of distinct function [4]. Biologically relevant isoform
differences range from subtle, such as a few nucleotides at an
alternative 5' or 3' splice site, to skipping several consecutive
exons. Variant isoforms can be specific to tissue types or
developmental stages and are involved in a large number of
normal cellular functions. Defects in splicing also account for
a substantial fraction of human genetic disease [5,6].
The most common ways to identify alternative splicing events
involve aligning and comparing EST and cDNA sequences
from the same gene [2,3,7-16]. These methods are effective,
but have significant limitations as a result of biases in tran-
script coverage and non-uniformity of tissue libraries or sam-
pling [15]. Reverse transcriptase polymerase chain reaction
(RT-PCR) experiments followed by sequencing may also be
used to discover novel isoforms. This approach can be power-
ful for analyzing a few genes in a small number of tissues, but
it only provides a limited view of a gene's structure and is
labor-intensive and challenging to scale up to thousands of
genes and hundreds of tissues.
The highly parallel and sensitive nature of microarrays makes
them ideal for monitoring gene expression on a tissue-
specific, genome-wide level [17,18]. Initial efforts have
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demonstrated that microarrays can be used to detect pre-
mRNA splicing [19-21]. However, these early efforts have sig-
nificant limitations. For instance, a typical experiment using
oligonucleotide microarrays involves a 3'-biased labeling pro-
tocol and by necessity a probe or probes placed near the 3' end
of the mRNA transcript [19]. This experimental set-up limits
discovery and monitoring of alternatively spliced isoforms to
regions near the 3' end of the transcript. Probe placements
within the 3' UTR [19], or not including probes spanning
exon-exon junctions [17], also limit the types of isoforms that
can potentially be monitored and detected. Methods using
fiber-optic arrays [20] require pre-selection of known iso-
forms of interest and were not designed for novel isoform dis-
covery. The utility of probes to exon junctions for measuring
intron retention in yeast has been demonstrated [21], but the
use of array probes was not experimentally optimized to mon-
itor and discover alternatively spliced isoforms in complex
human samples. In addition, the RNA labeling approach used
in the yeast system would not be appropriate for samples that
require an amplification step because of limited tissue or RNA
availability.
One contribution of this work is a full-length RNA amplifica-
tion protocol that samples complete transcripts. This pro-
vides an alternative to standard amplification methods that
prime from the 3' poly(A) tail and do not accurately reproduce
sequences distant from the 3' end. This new protocol gener-
ates sufficient material for several hybridizations from as lit-
tle as 5 µg total RNA or 50 ng mRNA as starting material. We
also provide the results of array experiments used to define
experimental parameters and analysis strategies for mapping
intron-exon structure and alternative splicing at high resolu-
tion. Together these methods facilitate high-throughput dis-
covery of alternative splicing events on a genomic scale.
Results and discussion
Our optimization efforts focused on two well characterized
genes, retinoblastoma (RB1) and synexin (ANXA7). We
selected  RB1  because it has a well characterized genomic
region [22] and a relatively large number (27) of exons,
whereas ANXA7 has two known isoforms that are differen-
tially expressed in smooth and skeletal muscle [23].
We sought to develop and optimize microarray-based meth-
ods of determining the structure of transcripts that scale eas-
ily to many genes and many tissues. The methods we describe
extend expression profiling to sub-exon resolution sufficient
for detecting and discriminating between alternative splice
forms. As alternative splicing might occur anywhere in a tran-
script, it is essential to use a protocol that labels the entire
length of a transcript. One solution is simply to random-
prime large amounts of mRNA using a one-step reverse tran-
scription reaction [17,21]. Although effective, this approach
requires more than approximately 1 µg mRNA for every one
to two hybridizations, which is unacceptably high for small or
rare tissue samples.
To address the sample-requirement issue, we developed a
full-length amplification protocol that combines random-
primed first- and second-strand synthesis steps with an
amplification strategy that uses both PCR and in vitro tran-
scription (IVT) (Figure 1). To verify that this protocol can ade-
quately represent entire transcripts, we amplified and labeled
Jurkat and K562 samples, and then hybridized both to an
array containing overlapping probes that step through the
mRNA of RB1. Figure 2 shows the probe intensities across the
mRNA transcript for this full-length protocol and for a
poly(A) 3'-labeling protocol. Only the full-length protocol
amplifies sequences more than 1,000 nucleotides from the 3'
transcript end. The reproducibility of the protocol was veri-
fied by independently amplifying replicate samples and
hybridizing them in opposing dye channels.
Flow chart of the full-length amplification and labeling protocol Figure 1
Flow chart of the full-length amplification and labeling protocol. The 
TotRP-Amp protocol (upper left) starts with total RNA whereas mRP-
Amp starts with mRNA. Both methods result in labeled complementary 
cDNA (ccDNA) sufficient for six hybridizations. dsDNA, double-stranded 
DNA. See Materials and methods for details.
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Exon definition
Distinguishing exonic regions from intron and intragenic
regions is a prerequisite for monitoring transcript structure.
To determine optimal probe length and hybridization condi-
tions for detecting and defining exons, we designed tiling
arrays with probes placed in one-nucleotide intervals across
Comparison of amplification protocols Figure 2
Comparison of amplification protocols. (a) Comparison of the full-length amplification protocol (mRP-Amp, blue) and a 3'-biased amplification protocol 
(black) of the RB1 gene in the Jurkat cell line. As expected, the 3' protocol amplifies the 3' end well but probe intensities greater than 1,000 nucleotides 
from the 3' end are near background levels. Background is defined by the mean intensity of 10,700 probes spaced throughout RB1 introns. (b) Comparison 
of the mRP-Amp protocol to random-primed reverse transcription (RP-RT) alone. The plot shows the log10 intensity ratios between Jurkat and K562 cell 
lines from 17,000 probes hybridized, where the Jurkat and K562 samples were amplified with either the mRP-Amp protocol (horizontal axis) or a 'gold 
standard' RP-RT protocol. (c) Two independent mRP-Amp amplifications of Jurkat and K562 cell lines demonstrate protocol reproducibility. Points show 
log10 intensity ratios of K562 to Jurkat from the probes complementary to the RB1 mRNA sequence.
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the entire 180-kilobase (kb) genomic region encoding the RB1
gene. Separate tiling arrays for probe lengths 20, 25, 30, 35,
40, 45, 50, and 60 nucleotides were hybridized with labeled
cDNA from two cell lines, Jurkat and K562, over a range of
stringencies controlled by adjusting the amount of forma-
mide in the hybridization buffer (20, 25, 30, 35, 40, and 45%
formamide). We found that detection sensitivity for finding
exons within genomic sequence, measured as the ratio
between the intensity of probes in exons and probes in
introns, peaks near 35% formamide and probe lengths of 50-
60 nucleotides. These results are consistent with prior studies
with ink-jet arrays [17,24].
Exon-edge detection
Although longer 60-nucleotide 'exon probes' are better for
detecting exons, shorter probes or higher formamide concen-
trations could be more accurate for pinpointing splice sites
between exons and adjacent introns. To optimize detection of
exon boundaries, we placed overlapping probes across all
exon-intron boundaries at one-nucleotide intervals from 100
nucleotides within the intron to entirely within the exon,
using the 27 exons of RB1 as a test case. We again varied probe
length, testing 20-, 25-, 30-, 35-, 40-, 45-, 50-, and 60-
nucleotide probes, as well as formamide concentrations,
probe-step intervals, and analysis methods. Figure 3 shows
the tiling intensity profiles for these 5' and 3' edge probes,
using 35-nucleotide probes in 30% formamide. Figure 4
shows the averaged exon-intron edge profile at a range of for-
mamide concentrations and probe lengths.
Several conclusions can be drawn from these data. First, exon
edges can be clearly identified by tiling at high resolution.
Second, the intensities of shorter probes fall off sharply at
exon boundaries, which may allow more precise estimates of
splice sites (see below). One can also observe in Figure 4 a
slight asymmetry in the probe intensity profiles extending
from the 5' and 3' sides of the exon. This effect, due to polarity
in probe sensitivity with respect to distance from the glass
surface, necessitates slightly different edge-detection param-
eters for each side of the exon.
Probe-intensity profiles for intron-exon boundaries (edges) of the 27 RB1 exons using 35-nucleotide probes and 30% formamide, where each color  represents a single exon Figure 3
Probe-intensity profiles for intron-exon boundaries (edges) of the 27 RB1 exons using 35-nucleotide probes and 30% formamide, where each color 
represents a single exon. (a) 3' splice sites (5' exon edge); (b) 5' splice sites (3' exon edge). These conditions allow accurate prediction of splice sites. The 
dashed line marks actual splice sites, by which the exons were aligned, and the small circles mark the predicted splice-site locations for each exon after 
convolution with the Haar wavelet (see Materials and methods for details). Although the short exon-10 sequence contains several AT-rich regions within 
the exon which hybridize poorly and create a dip in the intensity profile (lower magenta curve), the splice-site predictions for exon 10 are consistent with 
the others.
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To detect splice sites from tiling data, we tested several edge-
detection algorithms, including Gaussian, Haar, and b-spline
wavelets; Green's function deconvolution; and simple slope
estimates. The Haar wavelet was selected for its performance
and simplicity (see Materials and methods). Figure 5 shows
the predicted splice site locations for all 27 exons of RB1 rela-
tive to the correct location. The predicted locations have a
range of only 10-15 nucleotides (SD approximately 5 nucleo-
tides). At this resolution, splice-site sequence motifs [25,26]
could be used to identify the exact splice site location. The
accuracy of array-based predictions is also probe-length
dependent, such that 'mid-sized' 35-40-nucleotide probes
showed the most consistency over all 5' and 3' splice sites for
this microarray platform (Figure 5). Similar optimal parame-
ters were found for RB1 in Jurkat cells, where RB1 expression
is very high; for RB1 in K562 cells, where its expression is very
low; and for ANXA7 in both smooth and skeletal muscle (data
not shown).
The accuracy of splice-site detection was also measured for
different tiling step intervals. By computationally removing
data from the original one-nucleotide step dataset (with 30%
formamide and 35-nucleotide probes), we simulated data col-
lected from probes at step intervals of 2-10 nucleotides. In
Jurkat cells, where RB1 is highly expressed, edge-detection
accuracy remains high even as the step interval increased to
eight nucleotides between probes. However, in K562, the con-
sistency of the predicted location decreased significantly for
tiling step intervals greater than five nucleotides, suggesting
that this parameter is sensitive to the expression level of the
gene. In summary, splice sites can be detected by tiled micro-
a r r a y  ' e d g e '  p r o b e s  t o  a n  a c c u r a c y  o f  a p p r o x i m a t e l y  1 0
nucleotides, and step sizes equal to or less than five nucleo-
tides are sufficient for this accuracy.
Junction detection
The idea of using probes complimentary to exon-exon junc-
tions to monitor splicing was published as early as 2000 [4].
These probes span two exons and should be at maximum
intensity only when both exons are present and connected
[15,20,21]. Here we show the results of experiments aimed at
optimizing the use of junction probes (length, placement, and
hybridization stringency) for monitoring alternative splicing.
Using the RB1 transcript sequence, we generated arrays with
probes of eight different lengths (20-60 nucleotides) placed
in one-nucleotide steps across potential exon-exon junctions
and hybridized with Jurkat and K562 samples at several for-
mamide concentrations. As an example of the results, Figure
6 shows the intensities of the probes tiling across the junc-
tions between exon 9 and each of exons 10, 11, 12, and 13. The
naturally occurring exon 9 to exon 10 connection has the
highest-intensity signal, and centrally positioned probes offer
the greatest separation from the non-natural connections.
Similar results were found for the other 25 junctions of RB1
(data not shown).
The ability of junction probes to discriminate between true
exon-exon connections and false connections varied with
probe length (Figure 7). Interestingly, the longest probes
tended to show only a small intensity decrease across false
junctions - and thus have low specificity - because they have
substantial matching segments to each flanking exon. As seen
in Figure 7, for example, probes with lengths of 30-40
nucleotides placed near the center of the junction best detect
the non-connection of exon 9 and exon 12. We continued this
study over all combinations of stringency, probe length, and
probe position, and measured the percentage of junction
probes that correctly predicted the known exon junction. We
found optimal performance between 30 and 40% formamide,
35 to 40 nucleotides in length, and at positions centered over
the junction or less than five nucleotides off-center (data not
shown). The probe length range agrees with the choice of
Clark et al. [21] who used 40-mer probes to study splicing in
yeast on a different array platform.
To measure the sensitivity of junction probes to slight changes
in splice junction sequence, such as might be produced by an
alternative 5' or 3' splice site, we designed probes across com-
putationally 'mutated' junctions and tested their detection sen-
sitivity to naturally occurring mRNAs. For each of the 26 exon-
exon junctions of RB1, we created computational insertions of
1, 2, 3, 6, 9, 15, and 24 random nucleotides and deletions of 1,
2, 3, 6, 9, 15, and 24 nucleotides from each exon to simulate
mRNA nucleotide deletions and insertions, respectively. Tiling
probes were designed across each of these 'pseudo-junctions'
and hybridized with Jurkat mRNA. For most of the junctions,
there is a significant intensity reduction from even a single
nucleotide insertion or deletion (see Additional data file 1). For
others, like the exon 9 to exon 10 junction (Figure 8), differ-
ences were detectable for all mutations, but significant inten-
sity decreases were observed only when the difference was
three nucleotides or larger. Examination of all RB1 junctions
indicates that the most sensitive probe location is between the
junction center and five nucleotides towards the 3' end (data
not shown). We conclude that junction probes of 35 or 40
nucleotides placed near the junction center consistently detect
changes of three nucleotides or greater and frequently detect
changes of even one or two nucleotides.
One potential limitation of junction probes is that their loca-
tions are restricted and thus sensitive to base composition
differences. A probe may not report useful information, for
example, if one exon of a junction has a high GC percentage.
Using 35-nucleotide rather than 60-nucleotide probes
reduces the likelihood of a single exon hybridizing to half of
the probe. We also noticed that detection specificity was fur-
ther improved by normalizing the junction probe intensities
by subtraction of the two corresponding exon-intron 'edge
probe' intensities, which report the intensity contribution of
each half of the probe alone (see Additional data file 2). The
optimal conditions we have identified for probe length, probe
position, and formamide concentration are listed in Table 1.R66.6 Genome Biology 2003,     Volume 4, Issue 10, Article R66       Castle et al. http://genomebiology.com/2003/4/10/R66
Genome Biology 2003, 4:R66
Figure 4  (see legend on next page)
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Alternative splicing of the ANXA7 transcript
The methods described above were then applied to the alter-
natively spliced isoforms of ANXA7. Genomic mapping of the
ANXA7 transcript shows 14 exons, and previous studies [23]
have shown that a 66-nucleotide exon (exon 6) is absent in
smooth muscle but present in skeletal muscle. Tiling arrays
were designed with probes placed at one-nucleotide intervals
through the 39-kb genomic region of ANXA7. Exon-6 probes
had much higher intensities when hybridized with skeletal
muscle RNA than with smooth muscle RNA, as expected
(data not shown).
The ability of the exon probes to detect mixtures of two splice
forms in a single sample was tested quantitatively by combin-
ing fixed ratios of purified ANXA7 mRNA isoforms cloned
from smooth and skeletal muscle tissues (see Materials and
methods). Hybridization intensities from these samples were
compared to those from ANXA7  long form (from skeletal
muscle) alone. Figure 9 shows the difference between the two
channels: probe intensities outside of exon 6 have similar
magnitude, but probes in exon 6 have low intensity in smooth
muscle, indicating the absence of this exon. When compared
to 100% skeletal muscle (long form), the exon-skipping event
can be detected in mixtures as low as 20% short form, 80%
long form.
To test if junction probes alone can detect these two isoforms,
we generated probes for all combinations of exon junctions in
ANXA7 (exon 1 to exon 2, exon 1 to exon 3,..., exon 1 to exon
14, exon 2 to exon 3, and so on). Figure 10 shows microarray
results for both smooth and skeletal muscle. The highest nor-
malized probe intensities lie along the diagonal, showing that
each exon connects to adjacent exons. For example, in skele-
tal muscle, exon 5 connects to exon 6, which connects to exon
7. However, in smooth muscle, the off-diagonal probe repre-
senting the exon 5 to exon 7 connection hybridizes strongly
while the 5-6 and 6-7 probes do not, confirming that exon 6 is
skipped in smooth muscle. The first junction probe (1-2) does
not show measurable normalized intensity in either tissue,
which could be explained by incorrect sequence for exon 1,
poor amplification of that sequence region, unusual sequence
composition, or an alternative start site.
Extension to many tissues
The array-based methods described here offer ways to moni-
tor transcript structure that scale well to large numbers of tis-
sues. Junction probes provide a particularly simple and
Intensity profile of RB1 exon edges in Jurkat cells Figure 4
Intensity profile of RB1 exon edges in Jurkat cells. Median log intensities from 27 aligned exons show the edge profile for varying probe lengths (from 20 to 
60 nucleotides) and formamide concentrations (see key). As the exons have different sizes, the average probe intensity within each exon is reported by a 
horizontal line between the two '0' points. The horizontal axis indicates the distance between the 5' end of the probe and the splicing acceptor site on the 
left side of the figure, and the distance between the 3' end of the probe and the splicing donor site on the right side of the figure. RB1 is expressed at low 
levels in the cell line K562; nevertheless, these edge profiles (data not shown) are similar but with lower intensities.
Consistency of predicted splice site locations for the 27 exons of RB1 Figure 5
Consistency of predicted splice site locations for the 27 exons of RB1. (a) 
Standard deviation of the predicted locations in nucleotides relative to the 
correct site versus probe length, at 30% formamide using a 50-point Haar 
wavelet (b). Blue, exon 5' edge (3' splice site); red, exon 3' edge (5' splice 
site). No knowledge of splice-site sequence motifs (for example, GT-AG) 
was incorporated into the prediction process.
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efficient means of detecting alternative splicing events in a
high-throughput fashion. To demonstrate this, the splicing of
ANXA7 was monitored with junction probes in many differ-
ent human mRNA samples, and RT-PCR was used to validate
the array-based predictions. Figure 11 shows the RT-PCR and
microarray results from 22 tissues. Heart, spinal cord, and
many subregions of the brain show evidence of the long iso-
form in the array data, whereas other tissues do not. RT-PCR
reactions using primers complementary to ANXA7 exons 5
and 7 give product bands that correctly correspond to the two
expected isoforms (Figure 11). The correlation between the
microarray probe intensities and the products demonstrates
that junction probes can effectively discern the tissue distri-
butions of alternative isoforms, even in mixtures.
It is straightforward to extend the methods described here to
parallel measurements of larger numbers of genes and tis-
sues. As exon-exon junction probes can map transcript struc-
ture with a small number of probes, the alternative splicing
events of thousands of genes can be monitored simultane-
ously on the same array. By further modifying the amplifica-
tion protocol, we were able to use as little as 50 ng of mRNA
or 5 µg of total RNA as input, and we have automated the pro-
tocol to amplify and label 96 tissues simultaneously.
In summary, we have developed a protocol for effective full-
length RNA labeling and have optimized experimental and
computational microarray-based methods for determining
transcript structures at high resolution. With a combination
of finely spaced 'exon' and 'intron' probes, 'edge' probes, and
'junction' probes, these methods can: discriminate exons
from introns; detect splice sites at less than 10 nucleotides
resolution using array data alone; assemble and order exons
in a transcript using junction probe intensities; identify
changes in exon-exon junctions as small as one to three
nucleotides; and detect alternatively spliced isoforms which
are tissue-specific or present in mixtures. The experimental
and computational methods described here are currently
being used to carry out high-throughput detection of alterna-
tive splicing events on a genomic scale.
Materials and methods
Genomic mapping and array design
RB1 and ANXA7 mRNA sequences were mapped to genome
sequence based on the assembly available though the
National Center for Biotechnology Information (NCBI) [11]
using sim4 [27]. Repeat sequences were masked using the
Scylla repeat-masking program from Paracel (Pasadena, CA)
that uses the HASTE algorithm to identify repeat sequences,
including both simple and interspersed repeats [28]. Over-
lapping probes of lengths 20, 30, 40, 50, and 60 nucleotides
were designed at one-nucleotide steps: (1) throughout each
exon, (2) across each intron-exon edge, starting approxi-
mately 100 nucleotides into the intron, (3) across each exon-
exon junction as described in the preceding text, and (4) at
10-nucleotide steps through each intron. For 20-nucleotide
probes in ANXA7, for example, this resulted in 1,810 exon
probes, 3,156 edge probes, 4,387 junction probes (including
modified junctions), and 11,944 intron probes. For 20-
nucleotide probes in RB1, this resulted in 4,179 exon probes,
5,852 edge probes, 5,550 junction probes, and 7,529 intron
probes. All probes of lengths less than 60 nucleotides were
placed on stilts of 10 thymidines. Probe intensities were back-
ground corrected and log values were used. Oligonucleotide
arrays were synthesized on 1 × 3-inch glass slides with ink-jet
technology [24] using mRNA samples obtained from Clon-
tech (Palo Alto, CA) and the cell lines Jurkat (T lymphocyte,
ATCC no. TIB-152) and K562 (chronic myelogenous leuke-
mia, ATCC no. CCL-243).
Preparation of labeled cDNA
Hybridization material was generated through a random-
priming amplification procedure (RP-Amp) using primers
with a random sequence at the 3' end and a fixed motif at the
5' end. The following amplification protocol generated
enough labeled material for approximately 400 hybridiza-
tions starting from 1.5 µg of mRNA. shDNP256 (first-strand
synthesis): 5'-TAGATGCTGTTGNNNNNNNNN-3', and
shT7N9 (second-strand synthesis): 5'-ACTATAGGGA-
GANNNNNNNNN-3'. mRNA (1.5 µg) was reverse-tran-
scribed with Superscript II and the DP256 random primer for
20 min at 42°C (10 mM DTT, 50 mM Tris-HCl pH 8.3, 75 mM
KCl, 8 mM MgCl2, 0.5 mM dNTPs, 5 U/µl Superscript II). The
Dependence of negative discrimination on junction probe length Figure 7
Dependence of negative discrimination on junction probe length. Intensity 
of probes of different length tiled across the junction between exon 9 and 
exon 12, which are not connected in the RB1 transcript. Light blue, length 
30 nucleotides; red, 40; dark blue 50; green, 60. Vertical colored dotted 
lines mark where probes make a transition from completely within an 
exon to chimeric junction probes spanning both exons. At 35% 
formamide, the intensities of the 20-nucleotide probes are largely at 
background levels and are not shown, while 60-mers (green) show little 
decrease in signal while spanning a 'false' junction. Background level is 
shown by the black dashed line at the bottom of the figure.
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RNA was degraded with the addition of 20 µl volume of 0.5 N
sodium hydroxide and 0.25 M EDTA for 20 min at 65°C. The
single-stranded cDNA was purified using a commercial kit
(Qiagen Qiaquick). The resulting single-stranded cDNA prod-
uct was placed in its entirety in a second-strand reaction. Sec-
ond-strand synthesis reactions utilized shT7N9 random
primer and the Klenow fragment of DNA polymerase utilizing
standard reaction conditions (37°C for 60 min, 0.2 mM DTT,
2.1 mM Tris-HCl pH 7.9, 2.1 mM MgCl2, 10.7 mM NaCl, 1.07
mM dNTPs, 0.1 U/µl Klenow), followed by another Qiaquick
purification. Multiple PCRs were run using 0.15 µg double-
stranded (ds) DNA and standard reaction conditions. Ampli-
fication was achieved using 10 cycles of PCR with the DP256
and T7 primers (20 mM Tris-HCl pH 8.4, 50 mM KCl, 0.01
mM dNTPs, 1.5 mM MgCl2, 0.01 U/µl Taq Polymerase),
where DP256: 5'-GTTCGAGACCTCTAGATGCTGTTG-3', and
T7: 5'-AATTAATACGACTCACTATAGGGAGA-3', followed by
Qiaquick purification. Further amplification was achieved
using in vitro transcription reactions with 0.5 µg dsDNA and
T7 RNA polymerase (7.5 mM DTT, 40 mM Tris-HCl pH 7.5,
14.25 mM MgCl2, 10 mM NaCl, 2 mM spermidine, 125 U/ml
RNAguard, 2.5 mM dNTPs, 15 U/ml IPPase, 25 kU/ml T7
polymerase) for 16 h at 42°C. The cRNA was purified (RNe-
asy) and reverse transcribed using Superscript II, random 9-
mers, and amino-allyl dUTP (42°C for 20 min, 10 mM DTT,
50 mM Tris-HCl pH 8.3, 75 mM KCl, 8 mM MgCl2, 0.5 mM
dNTPs, 0.5 mM amino-acyl-dUTP, 5 U/µl Superscript II).
The final product was coupled to Cy3 or Cy5 dye in 1 M bicar-
bonate buffer for 1 h. Reactions were finished with the addi-
tion of 4 M hydroxylamine followed by purification. The
percentage dye incorporation and total cDNA yield were
determined spectrophotometrically. Formamide concentra-
tions in the hybridization solution were adjusted while keep-
ing the overall volume at 2 ml. Pairs of Cy3/Cy5-labeled
Sensitivity of junction probes to small sequence variations Figure 8
Sensitivity of junction probes to small sequence variations. Tiling probes were stepped across RB1 exon-exon junctions incorporating artificial (a) 
insertions or (b) deletions simulating mRNA nucleotide deletions and insertions, respectively. Nucleotides were deleted separately from each exon of a 
junction, resulting in two intensity profiles for each deletion size, averaged together in the lower panel. Data are from 40-mers spanning exon 9 to exon 10 
pseudojunctions, hybridized with Jurkat mRNA in 35% formamide.
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cDNA samples were combined and hybridized as described
previously [29]. Arrays were hybridized for 48 h then washed
and scanned on Agilent Microarray Scanners.
A higher-throughput version of the above protocol was
designed for use with automation and a lower requirement
for total RNA. This was accomplished by modifying a
magnetic bead-based mRNA extraction (Ambion, Poly(A)
Purist) for use with a Biomek FX and 96-well plates. Starting
with as little as 5 µg total RNA (totRP-Amp) or 50 ng mRNA
(mRP-Amp) will yield enough material for six dye-coupled
hybridizations. The entire mRNA yield was used for first-
strand synthesis. Subsequent steps were performed as above,
except that reaction purifications were done using 96-well
Table 1
Optimal probe lengths, probe positions, and formamide concentrations for purposes of exon monitoring, exon edge detection, and 
exon-exon junction monitoring
Exon monitoring Exon-edge detection Junction monitoring
Probe size 50 to 60 nucleotides 35 nucleotides 35 to 40 nucleotides
Probe position Exon interior = 5-nucleotide steps Centered ± 5 nucleotides
Formamide concentration 35% 30% 30 to 40%
Detection of isoform mixtures in a single sample, using purified ANXA7 RT-PCR products from skeletal (Sk) and smooth (Sm) muscle and 60-nucleotide  probes Figure 9
Detection of isoform mixtures in a single sample, using purified ANXA7 RT-PCR products from skeletal (Sk) and smooth (Sm) muscle and 60-nucleotide 
probes. Both isoforms can be detected when the shorter isoform, without exon 6, makes up 20% or more of the mixture. Plotted are log-ratios between 
intensities after normalizing on the basis of intensities of probes within unaffected exons. Blue and green lines trace exon and junction probe intensities, 
respectively; numbers are exon numbers. This experiment was performed for mixtures of 0, 20, 40, 60, 80, and 100% smooth muscle (see Additional data 
file 3).
100% Sk versus (100% Sm, 0% Sk)
3 4 5 6 7 8 9 10
200 300 400 500 600 700 800 900 1,000 1,100
100% Sk versus (20% Sm, 80% Sk)
Distance (nucleotides) of probe center from mRNA 5′ edge 
L
o
g
1
0
 
r
a
t
i
o
L
o
g
1
0
 
r
a
t
i
o
0.2
0.1
0
−0.1
−0.2
2.5
2
1.5
0.5
1
0
−0.5http://genomebiology.com/2003/4/10/R66 Genome Biology 2003,     Volume 4, Issue 10, Article R66       Castle et al. R66.11
c
o
m
m
e
n
t
r
e
v
i
e
w
s
r
e
p
o
r
t
s
r
e
f
e
r
e
e
d
 
r
e
s
e
a
r
c
h
d
e
p
o
s
i
t
e
d
 
r
e
s
e
a
r
c
h
i
n
t
e
r
a
c
t
i
o
n
s
i
n
f
o
r
m
a
t
i
o
n
Genome Biology 2003, 4:R66
Qiaquick and RNeasy products. All material from the first-
strand synthesis, second-strand synthesis, and PCR was con-
centrated by means of evaporation and used in its entirety
without quantitation.
RT-PCR of ANXA7
We designed primers to exons flanking the cassette exon,
used the Qiagen OneStep RT-PCR kit, and resolved the RT-
PCR products on 2% agarose gels. Forward primer: 5'-
TTCACAGTCTTATGGAGGTGGT-3'; reverse: 5'-CTTACGAA-
GAATTTCTGCATCTC-3'.
ANXA7 mixture experiments
A cDNA representing exon 2 to exon 10 of ANXA7
(NM_004034) was generated with the T7 motif at the 5' end
in a two-step reaction. Skeletal muscle mRNA was used to
generate the long form (1,026 base-pairs (bp)) and smooth
muscle mRNA to generate the short form (940 bp). RT-PCR
was performed with the ANXA7-specific primers followed by
additional rounds of PCR to incorporate the T7. In vitro tran-
scription of this cDNA generated cRNA that was subsequently
reverse transcribed using Superscript and random 9-mers
and amino-allyl dUTP. The percentage dye incorporation and
total cDNA yield were determined spectrophotometrically
and the long and short forms were combined in the following
ratios (5:0, 4:1, 3:2, 1:4, 0:5) with a final mass of 500 ng for
each hybridization. ANXA121: 5'-GTCAGGAGTCATCTTTTC-
CCCCTTC-3'; ANXA1147: 5'-AGATTCATCGGTC-
CCTAGTCTCCCC-3'; T7ANXA121: 5'-
ACTATAGGGAGAGTCAGGAGTCATC-3'
Calculation of exon edges
To estimate splice-site positions from tiling data, we tested
Green's function deconvolution, derivative estimates, and
wavelets. For the Green's function deconvolution method, we
averaged probes placed across all 27 RB1 intron-exon bound-
aries to generate 5' and 3' intensity profiles of intron-exon
edges. For each intron-exon boundary, this averaged profile
was deconvolved from probe intensities; ideally, this should
result in a spike marking the intron-exon boundary, but this
method was sensitive to noise. We also tested using the deriv-
ative of each smoothed intron-exon profile. Finally, we also
tested convolving each intron-exon intensity profile with
wavelets, including Haar wavelets (step functions), b-spline
wavelets, and Gaussian wavelets. For each of the wavelets, we
varied the size of the wavelet and, for the Gaussian wavelets,
the number of zero-crossings. Of the Green's function, deriv-
ative, and wavelet methods, we chose a 50-point Haar wavelet
on the basis of its performance and simplicity. Thus, to esti-
mate intron-exon boundary, we convolved this 50-point Haar
wavelet with each intron-exon probe intensity profile, start-
ing 100 nucleotides into the intron through the exon, and
identified the maximum value. The location of the maximum
does not coincide with the splice site, but is a constant offset
ANXA7 junction probe intensities for all possible pairwise combinations of exons hybridized with (a) smooth muscle and (b) skeletal muscle samples Figure 10
ANXA7 junction probe intensities for all possible pairwise combinations of exons hybridized with (a) smooth muscle and (b) skeletal muscle samples. 
Probes are 40 nucleotides, centrally positioned, and the hybridization used 35% formamide. Intensities have been normalized by the corresponding 'edge 
probe' intensities (see text) and the maximum in each plot is scaled to one. The 5' exon of each pair is numbered on the vertical axis, and the 3' exon on 
the horizontal axis.
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from the splice site. This constant depends on probe length,
can be found by profiling through known intron-exon edges
(for example in RB1) and subsequently applied to new data.
Note added in proof
While this article was under review, a related article was pub-
lished by Wang et al. [30] who describe an algorithm for
determining the relative abundance of known alternative iso-
forms from microarray data. This article makes an important
contribution to analysis methods for monitoring mRNA iso-
form levels using multiple oligonucleotide probes and is a
useful complement to the work presented here.
Additional data files
Additional data, available with this article online, include a
figure showing the optimization of formamide concentration
and probe length for detecting insertions and deletions in
exon-exon junctions (Additional data file 1), a figure showing
the  ANXA7  junction probe intensities for all pairwise
combinations of exons (with 40-nucleotide probes, centrally
positioned, in 35% formamide, without 'edge probe' normali-
zation) (Additional data file 2), and a figure illustrating the
detection of isoform mixtures in a single sample (using puri-
fied ANXA7 RT-PCR products from skeletal and smooth mus-
cle over a series of isoform ratios) (Additional data file 3).
Additional data file 1 A figure showing the optimization of formamide concentration and  probe length for detecting insertions and deletions in exon-exon  junctions A figure showing the optimization of formamide concentration and  probe length for detecting insertions and deletions in exon-exon  junctions Click here for additional data file Additional data file 2 A figure showing the ANXA7 junction probe intensities for all pair- wise combinations of exons A figure showing the ANXA7 junction probe intensities for all pair- wise combinations of exons Click here for additional data file Additional data file 3 A figure illustrating the detection of isoform mixtures in a single  sample A figure showing the ANXA7 junction probe intensities for all pair- wise combinations of exons Click here for additional data file
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